Internet-based vestibular rehab produces similar results to written instructions for home exercise
TUESDAY, June 23, 2026 (HealthDay News) — Internet-based vestibular rehabilitation (VR) is not superior to written instructions for reducing vestibular symptoms six weeks after acute-onset vertigo, according to a study published online June 12 in PLOS ONE.
Solmaz Surano, M.D., Ph.D., from Umeå University in Sweden, and colleagues evaluated the efficacy of an internet-based VR tool for reducing vestibular symptoms after acute-onset vertigo. The analysis included 183 adults with ongoing acute vestibular syndrome (recruited within seven days after symptom onset) who were randomly assigned to six weeks of internet-based VR with personalized, progressively adjusted home exercises or to written instructions for home-based VR exercises.
The researchers found that both groups improved at six weeks, with no significant between-group difference (adjusted mean difference, −2.0 points; 95 percent confidence interval, −4.9 to 0.9; P = 0.18). Both groups showed reduced vestibular symptoms and improved disability, balance, and walking speed, without significant between-group differences over 12 weeks. There were no serious adverse events, and compliance was high in both groups.
“These findings suggest that ensuring access to vestibular rehabilitation exercises may be more important than the specific mode of delivery after acute-onset vertigo, and internet-based tools represent viable alternatives for patients who prefer or may benefit from a digital format,” the authors write.
One author disclosed ties to the health technology industry.
Women With Cerebral Palsy Receive Less Preventive Gynecological Care
People With ADHD Experience 50 Percent More GI Symptoms
1 in 4 Former NFL Players Had CTE at Death in 2016 to 2021
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy
Voice Disorders Linked to Elevated Risk for Incident Cognitive Decline
Therapies Compared for Newly Diagnosed Multiple Sclerosis
Initial Rx Length Tied to Long-Term Use of Z-Drugs
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease